Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$46.90M
↑ 370% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-17.37M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $46.90M | +167.7% |
| 2024 | $-69.31M | -177.9% |
| 2023 | $-24.94M | -19.9% |
| 2022 | $-20.79M | +25.2% |
| 2021 | $-27.79M | -10.2% |
| 2020 | $-25.23M | -45.0% |
| 2019 | $-17.40M | -48.8% |
| 2018 | $-11.69M | -17.5% |
| 2017 | $-9.95M | +26.5% |
| 2016 | $-13.54M | - |